Grant ID PP170121
Awarded On February 21, 2018
Title Evidence-Based Hepatocellular Cancer Prevention through Targeted Hepatitis C Screening and Navigation
Program Prevention
Award Mechanism Evidence-Based Prevention Programs and Services
Institution/Organization The University of Texas Southwestern Medical Center
Principal Investigator/Program Director Mamta Jain
Cancer Sites Gallbladder, Liver and Intrahepatic Bile Duct
Contracted Amount $1,300,994
Lay Summary

The most common primary liver cancer is hepatocellular carcinoma (HCC). Estimates of highest incidence in the US are known to be in areas with elevated prevalence for hepatitis C virus (HCV) infection. Therefore, early detection and treatment of HCV will support HCC prevention for which hepatitis C infection is the main risk factor.

Texas maintains the 2nd highest incidence rate for HCC in the nation at 9.1/100,000 persons and HCC is the fastest growing cancer in the state. Of the 3,031 cases that occurred in Texas in 2015, nearly 8% will occur in Tarrant County and surrounding areas–the project service area. Barriers to addressing HCV and associated HCC include knowledge gaps at both...

Read More